Skip to content
★ Sign in to follow
YM
Total declarations
9
Company
1
▲ Purchases (9 ops.)
€15k
▼ Sales (0 ops.)
—

Latest filing published 25 Apr 2008 for Opus Genetics, Inc., €1,498.

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
9
Positive at T+90
0%
Median T+90
-7.9%

Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 25 Apr 2008 · 6772 days ago · €1,498
    -72.5%
    Entry US$1,152.00 · Close at T+365 US$316.80

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Y. Michele Kang: trading record in brief

All filings by Y. Michele Kang on record concern Opus Genetics, Inc. The record holds 9 filings, for trades running from 23 April 2008 to 24 April 2008.

No open-market sale appears; the market trades are 9 purchases worth €15k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €1,498. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -7.9%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 25 April 2008: an open-market purchase of €1,498, in Opus Genetics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Y. Michele Kang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    2,350 USD0SEC
    1,000 shares@ US$2.35Common StockSEC:0001140361-08-010311:0
    Canonical exit: 22 Jul 2008 (T+90)
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    2,300 USD0SEC
    1,000 shares@ US$2.30Common StockSEC:0001140361-08-010311:4
    Canonical exit: 22 Jul 2008 (T+90)
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    5,750 USD0SEC
    2,500 shares@ US$2.30Common StockSEC:0001140361-08-010311:5
    Canonical exit: 22 Jul 2008 (T+90)
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    1,125 USD0SEC
    500 shares@ US$2.25Common StockSEC:0001140361-08-010311:6
    Canonical exit: 22 Jul 2008 (T+90)
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    1,175 USD0SEC
    500 shares@ US$2.35Common StockSEC:0001140361-08-010311:7
    Canonical exit: 23 Jul 2008 (T+90)
  • ▲
    DirectorExecutivesOpus Genetics, Inc.
    3,525 USD0SEC
    1,500 shares@ US$2.35Common StockSEC:0001140361-08-010311:8
    Canonical exit: 23 Jul 2008 (T+90)

6 of 6 declarations